Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine

自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发

基本信息

  • 批准号:
    10205730
  • 负责人:
  • 金额:
    $ 14.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Administrative Core A Project Summary The Administrative Core will provide the administrative support necessary for coordination of research activities between the five projects and the Scientific Core. The Administrative Core will assist the Center Director, Scientific Core and Project Leaders by achieving the following aims: Aim 1: To provide the organizational capacity to coordinate, supervise, and manage all HCV Vaccine Research Program activities, including integration and coordination of research aims. Aim 2: To provide fiscal oversight and assist Project Leaders with administrative aspects of their projects. Aim 3: To maintain adherence with human subjects and other regulatory guidelines. Aim 4: To oversee data management and analysis and manage the data sharing plan. Through these aims, the Administrative Core will be responsible for: 1) Coordinating, supervising, identifying and resolving problems, and managing all research program activities, which includes sponsoring activities to advance the research program’s integration. 2) Providing a supportive structure sufficient to ensure the accomplishment of all research program goals. 3) Assisting Core and Research Project Leaders with administrative aspects of their projects, such as gathering of annual progress reports and facilitating other communications. 4) Promoting collaboration and coordination among Core and Research Project Leaders. 5) Fostering outreach activities to promote collaborations with the pertinent scientific communities. 6) Communicating with NIAID and with other awarded research programs regarding collaboration and coordination of activities and projects.
行政核心A项目摘要 行政核心将为协调研究活动提供必要的行政支持 五个项目和科学核心之间的联系行政核心将协助中心主任, 科学核心和项目领导人,实现以下目标:目标1:提供组织 协调、监督和管理所有HCV疫苗研究计划活动的能力,包括 研究目标的整合与协调。目标2:提供财务监督并协助项目负责人 他们项目的行政方面。目的3:维持对人类受试者和其他受试者的依从性 监管准则。目标4:监督数据管理和分析,并管理数据共享计划。 通过这些目标,行政核心将负责:1)协调、监督、确定 和解决问题,并管理所有的研究计划活动,其中包括赞助活动, 推进科研项目的整合。2)提供一个足够的支撑结构,以确保 实现所有研究计划目标。3)协助核心和研究项目负责人, 项目的行政方面,如收集年度进展报告和促进其他 通讯4)促进核心和研究项目负责人之间的合作和协调。第五章) 促进外联活动,以促进与相关科学界的合作。六、 与NIAID和其他获奖研究项目就合作和 协调各项活动和项目。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREA L COX其他文献

ANDREA L COX的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREA L COX', 18)}}的其他基金

Admin-Core-001
管理核心-001
  • 批准号:
    10710090
  • 财政年份:
    2022
  • 资助金额:
    $ 14.01万
  • 项目类别:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发
  • 批准号:
    10614971
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发
  • 批准号:
    10205729
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发
  • 批准号:
    10205731
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发
  • 批准号:
    10398149
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
控制多种 HCV 感染的 T 细胞的免疫学和代谢特征
  • 批准号:
    10398150
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection
SARS-CoV-2 感染急性后遗症中的性别、肥胖、免疫代谢和病毒持续性
  • 批准号:
    10554731
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发
  • 批准号:
    10398147
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发
  • 批准号:
    10398148
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
自发和疫苗介导的丙型肝炎病毒控制机制指导新型丙型肝炎疫苗的合理开发
  • 批准号:
    10671902
  • 财政年份:
    2021
  • 资助金额:
    $ 14.01万
  • 项目类别:

相似海外基金

A study for cross borders Indonesian nurses and care workers: Case of Japan-Indonesia Economic Partnership Agreement
针对跨境印度尼西亚护士和护理人员的研究:日本-印度尼西亚经济伙伴关系协定的案例
  • 批准号:
    22KJ0334
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
NSF-NOAA Interagency Agreement (IAA) for the Global Oscillations Network Group (GONG)
NSF-NOAA 全球振荡网络组 (GONG) 机构间协议 (IAA)
  • 批准号:
    2410236
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Cooperative Agreement
Conditions for U.S. Agreement on the Closure of Contested Overseas Bases: Relations of Threat, Alliance and Base Alternatives
美国关于关闭有争议的海外基地协议的条件:威胁、联盟和基地替代方案的关系
  • 批准号:
    23K18762
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
MSI Smart Manufacturing Data Hub – Open Calls Grant Funding Agreement
MSI 智能制造数据中心 – 公开征集赠款资助协议
  • 批准号:
    900240
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Collaborative R&D
Challenges of the Paris Agreement Exposed by the Energy Shift by External Factors: The Case of Renewable Energy Policies in Japan, the U.S., and the EU
外部因素导致的能源转移对《巴黎协定》的挑战:以日本、美国和欧盟的可再生能源政策为例
  • 批准号:
    23H00770
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Continuation of Cooperative Agreement between U.S. Food and Drug Administration and S.C. Department of Health and Environmental Control (DHEC) for MFRPS Maintenance.
美国食品和药物管理局与南卡罗来纳州健康与环境控制部 (DHEC) 继续签订 MFRPS 维护合作协议。
  • 批准号:
    10829529
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
National Ecological Observatory Network Governing Cooperative Agreement
国家生态观测站网络治理合作协议
  • 批准号:
    2346114
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Cooperative Agreement
The Kansas Department of Agriculture's Flexible Funding Model Cooperative Agreement for MFRPS Maintenance, FPTF, and Special Project.
堪萨斯州农业部针对 MFRPS 维护、FPTF 和特别项目的灵活资助模式合作协议。
  • 批准号:
    10828588
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
Robust approaches for the analysis of agreement between clinical measurements: development of guidance and software tools for researchers
分析临床测量之间一致性的稳健方法:为研究人员开发指南和软件工具
  • 批准号:
    MR/X029301/1
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Research Grant
FER (H&L) AMR PACE (A-0438) grant funding agreement
费率(H
  • 批准号:
    107541
  • 财政年份:
    2023
  • 资助金额:
    $ 14.01万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了